[Form 4] Weyco Group Inc Insider Trading Activity
Kevin Schiff, identified as an officer (VP, President - Florsheim) of Weyco Group Inc. (WEYS), reported acquiring 1,695 shares of the issuer on 08/25/2025 at a price of $0, bringing his total beneficial ownership to 29,250 shares. The Form 4 shows this non‑derivative transaction and lists his existing derivative holdings in Weyco stock options.
The filing also discloses four series of outstanding stock options exercisable into common stock: 1,200 shares at $18 (exp. 08/26/2030), 2,401 shares at $24 (exp. 08/25/2031), 2,341 shares at $28.83 (exp. 08/25/2032), and 3,121 shares at $25.79 (exp. 08/25/2033). Each option grant vests at 20% per year for five years beginning on the listed grant date for each series.
- Insider ownership increased by 1,695 shares, bringing total beneficial ownership to 29,250 shares.
- Clear option disclosure with exercise prices and expirations, and explicit vesting schedules of 20% per year for five years, enhancing transparency.
- None.
Insights
TL;DR: Routine officer share acquisition and disclosure of outstanding option grants; increases insider ownership but appears administrative rather than market-moving.
The Form 4 documents an acquisition of 1,695 common shares at a reported price of $0, raising the reporting person’s beneficial ownership to 29,250 shares. The filing also inventories four option tranches with exercise prices from $18.00 to $28.83 and expirations through 2033, each vesting 20% annually over five years. For investors, this confirms insider stake and the timeline for potential option exercises, but contains no earnings, disposition of large holdings, or unusual compensation terms disclosed in the filing.
TL;DR: Standard Section 16 disclosure showing an officer’s issuance/acquisition and scheduled option vesting; governance implications limited and routine.
The report identifies Kevin Schiff as an officer (VP, President - Florsheim) and provides clear disclosure of both non‑derivative and derivative holdings. The 20% per year vesting schedules are explicitly stated for each option grant, providing transparency on future insider alignment with long‑term performance. The filing contains no indication of special arrangements, related‑party transfers, or unusual accelerating events; it meets routine reporting expectations under Section 16.